The French E3N Prospective Cohort Study

Active, not recruitingOBSERVATIONAL
Enrollment

100,000

Participants

Timeline

Start Date

June 15, 1990

Primary Completion Date

November 15, 1991

Study Completion Date

December 15, 2025

Conditions
Breast CancerColo-rectal CancerParkinson DiseaseAsthmaDiabetesInflammatory Bowel DiseasesMelanomaEndometriosisThyroid CancerHypertensionEndometrial CancerCrohn DiseaseDepressionCardiovascular Diseases
All Listed Sponsors
collaborator

Université Paris-Sud

OTHER

collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

collaborator

Ligue contre le cancer, France

OTHER

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV